Nordic Medtech was formed in April 2019 with a clear vision and mission: To become a leading supplier of Artificial Intelligence in medical imaging.
Artificial intelligence is already becoming an over-used term. What Nordic Medtech means by this is what is usually referred to as Machine Learning or Deep Learning, meaning computers learning – and getting better – by processing large amounts of data. Deep learning can involve processing billions of medical images within one and the same diagnostic area.
Our partner icometrix have worked for a number of years with deep learning within diagnostics and treatment of some of the world’s most difficult and expensive neurological diseases: Multiple Sclerosis, Dementia, Alzheimer’s Disease, Brain Trauma and (soon available) Epilepsy. Clinical studies have shown treatments to be shortened by up to 70%. The solutions are fully approved by both American Food and Drug Administration (FDA) as well as CE-marked under the EU Medical Device Directory (MDD).